CELLECHO INC

Biotech · Private

Microchip-based platform using sound waves and electric fields to manipulate cells and deliver genetic material for multiplex cell engineering

Grants
$305K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: A Microprocessor for Complex, Multidimensional Cell Reprogramming: Acoustic-Electric Micro-Vortices Technology for Precise, Sequential Delivery of Genetic Molecules$305,000
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2139NOVATARG, INC.——
2140Helix Alternative Technologies Inc.—$6.0M
2141ImmunoMolecular Therapeutics, Inc.—$11M
2142CELLECHO INC——
2143Calico——
2144Scinai Immunotherapeutics Ltd.—$3.0M
2145ISOLERE BIO INC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.